Digital Technologies: Pharma’s Answer to Achieving Net Zero Emissions?
In June of this year, the Pacific Northwest battled unprecedented “heat domes,” which climate scientists agree would not have occurred in the absence of man-made…
Pharma
How AI and ML is Driving Value for Global Pharma Players
Today, we can enjoy innovations that were once considered science fiction, thanks to Data Science. Machine Learning (ML) and Artificial Intelligence (AI) have revolutionized the…
Leading Clinical Technology Providers Join Forces to Tackle Key Clinical Trial Pain Point
uMotif and Xperiome, a global healthtech company specialising in rare disease are to collaborate through a partnership that will bring value to both life science…
How Rep Relationships Open Digital Doors to HCPs
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
The Business of Biospecimen Procurement needs to be Revised
The journey of a biospecimen used for medical research begins with the donor and ends in a research laboratory. What happens between those two points…
Digital Pharma Manufacturing Revolution In Cases
Top-level management from pharma companies and IT leaders from the manufacturing and packaging sector get together at Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) on…
Four Steps for CROs Embarking on a Permanent Digital Transformation
The events of 2020 changed how the life sciences industry works – possibly forever. Prior to the emergence of COVID-19, some Contract Research Organisations (CROs)…
Defining the Evolving Role of the Pharmacist
The pressures on overstretched NHS resources are well documented and well understood. With increasing focus on better integrated and connected care in the community, especially…
The Future of Pharma – Remote Working Post-covid
Throughout 2020, Covid-19 forced significant changes to the global workforce as remote working became an overnight necessity. Fortunately, many of these changes had already begun…
Proving Long-term Value in Advanced Therapies: Digital technologies can measure durability of effect
“Nature abhors a vacuum,” and health technology assessment (HTA) bodies and payers hate uncertainty. Unfortunately, when it comes to advanced therapy medicinal products (ATMPs), they…